Your browser doesn't support javascript.
loading
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.
Zhang, Haiying; Freitas, Daniela; Kim, Han Sang; Fabijanic, Kristina; Li, Zhong; Chen, Haiyan; Mark, Milica Tesic; Molina, Henrik; Martin, Alberto Benito; Bojmar, Linda; Fang, Justin; Rampersaud, Sham; Hoshino, Ayuko; Matei, Irina; Kenific, Candia M; Nakajima, Miho; Mutvei, Anders Peter; Sansone, Pasquale; Buehring, Weston; Wang, Huajuan; Jimenez, Juan Pablo; Cohen-Gould, Leona; Paknejad, Navid; Brendel, Matthew; Manova-Todorova, Katia; Magalhães, Ana; Ferreira, José Alexandre; Osório, Hugo; Silva, André M; Massey, Ashish; Cubillos-Ruiz, Juan R; Galletti, Giuseppe; Giannakakou, Paraskevi; Cuervo, Ana Maria; Blenis, John; Schwartz, Robert; Brady, Mary Sue; Peinado, Héctor; Bromberg, Jacqueline; Matsui, Hiroshi; Reis, Celso A; Lyden, David.
Afiliação
  • Zhang H; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. haz2005@med.cornell.edu.
  • Freitas D; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Kim HS; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Fabijanic K; Institute of Molecular Pathology and Immunology of University of Porto, Ipatimup, Porto, Portugal.
  • Li Z; Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
  • Chen H; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Mark MT; Yonsei Cancer Center, Division of Medical Oncology, Departments of Internal Medicine, and Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
  • Molina H; Department of Chemistry and Biochemistry, City University of New York, Hunter College, New York, NY, USA.
  • Martin AB; Metabolomics Center, University of Illinois, Urbana, IL, USA.
  • Bojmar L; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Fang J; Department of Surgical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Rampersaud S; Proteomics Resource Center, The Rockefeller University, New York, NY, USA.
  • Hoshino A; Proteomics Resource Center, The Rockefeller University, New York, NY, USA.
  • Matei I; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Kenific CM; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Nakajima M; Department of Chemistry and Biochemistry, City University of New York, Hunter College, New York, NY, USA.
  • Mutvei AP; Department of Chemistry and Biochemistry, City University of New York, Hunter College, New York, NY, USA.
  • Sansone P; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Buehring W; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Wang H; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Jimenez JP; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Cohen-Gould L; Department of Pharmacology, Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.
  • Paknejad N; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Brendel M; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Manova-Todorova K; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Magalhães A; Microscopy & Image Analysis Core Facility, Weill Cornell Medicine, New York, NY, USA.
  • Ferreira JA; Microscopy & Image Analysis Core Facility, Weill Cornell Medicine, New York, NY, USA.
  • Osório H; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Silva AM; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Massey A; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cubillos-Ruiz JR; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Galletti G; Institute of Molecular Pathology and Immunology of University of Porto, Ipatimup, Porto, Portugal.
  • Giannakakou P; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Cuervo AM; Institute of Molecular Pathology and Immunology of University of Porto, Ipatimup, Porto, Portugal.
  • Blenis J; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Dr. António Bernardino de Almeida, Porto, Portugal.
  • Schwartz R; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Brady MS; Institute of Molecular Pathology and Immunology of University of Porto, Ipatimup, Porto, Portugal.
  • Peinado H; Medical Faculty, University of Porto, Al. Prof. Hernâni Monteiro, Porto, Portugal.
  • Bromberg J; LAVQ-REQUIMTE/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.
  • Matsui H; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Reis CA; Microbiology & Immunology in Obstetrics and Gynecology, Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA.
  • Lyden D; Pharmacology in Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Nat Cell Biol ; 20(3): 332-343, 2018 03.
Article em En | MEDLINE | ID: mdl-29459780
ABSTRACT
The heterogeneity of exosomal populations has hindered our understanding of their biogenesis, molecular composition, biodistribution and functions. By employing asymmetric flow field-flow fractionation (AF4), we identified two exosome subpopulations (large exosome vesicles, Exo-L, 90-120 nm; small exosome vesicles, Exo-S, 60-80 nm) and discovered an abundant population of non-membranous nanoparticles termed 'exomeres' (~35 nm). Exomere proteomic profiling revealed an enrichment in metabolic enzymes and hypoxia, microtubule and coagulation proteins as well as specific pathways, such as glycolysis and mTOR signalling. Exo-S and Exo-L contained proteins involved in endosomal function and secretion pathways, and mitotic spindle and IL-2/STAT5 signalling pathways, respectively. Exo-S, Exo-L and exomeres each had unique N-glycosylation, protein, lipid, DNA and RNA profiles and biophysical properties. These three nanoparticle subsets demonstrated diverse organ biodistribution patterns, suggesting distinct biological functions. This study demonstrates that AF4 can serve as an improved analytical tool for isolating extracellular vesicles and addressing the complexities of heterogeneous nanoparticle subpopulations.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Fracionamento Celular / Nanopartículas / Exossomos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Fracionamento Celular / Nanopartículas / Exossomos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article